Schedule 13D ownership disclosure

FSD PHARMA INC

Security class unavailable · CUSIP: 35954B206

Event date: 2021-02-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,841,342
Percent of class
9.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-21-001815
Form type
SC 13D
Filer
Bokhari Raza
CIK
CIK 1660525
Filed
Feb 22, 2021
Reporting period
Feb 17, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub